Skip to main content

Find Clinical Trials

Home
Conditions
Oligodendroglioma

Clinical trial condition

Oligodendroglioma

Explore clinical trials studying Oligodendroglioma. Study availability and eligibility vary by location and protocol.

301 public trials 22 recruiting studies

Refine in advanced search Browse all conditions

Oligodendroglioma trial results

Completed

Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma

NCT00005637

Conditions: Astrocytoma, Brain and Central Nervous System Tumors, Central Nervous System Neoplasms, +15 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Imatinib Mesylate and Temozolomide in Treating Patients With Malignant Glioma

NCT00354068

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +17 more
Locations: Duke Cancer Institute Durham, North Carolina, United States

View Trial Details

Completed

PH I Addition of Farnesyl Transferase Inhibitor to Temozolomide for Pts w Gr 3 & 4 Malignant Gliomas

NCT00612651

Conditions: Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +17 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors

NCT00002754

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +29 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary Brain Tumors

NCT00003478

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +20 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma

NCT00301873

Conditions: Astrocytoma, Bone Diseases, Bone Diseases, Metabolic, +24 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Recurrent Gliomas

NCT00002753

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +20 more
Locations: Duke Comprehensive Cancer Center Durham, North Carolina, United States

View Trial Details

Completed

Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

NCT00544284

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +40 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

City of Hope Medical Group Pasadena, California, United States

View Trial Details

Completed

O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors

NCT00003765

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +27 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

University of California San Diego Cancer Center La Jolla, California, United States

Children's Hospital Los Angeles Los Angeles, California, United States

Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View all 56 locations

View Trial Details

Completed

Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma

NCT00006102

Conditions: Astrocytoma, Brain Diseases, Brain Neoplasms, +55 more
Locations: University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States

University of South Alabama Medical Center Mobile, Alabama, United States

Phoenix Children's Hospital Phoenix, Arizona, United States

Arizona Cancer Center Tucson, Arizona, United States

View all 226 locations

View Trial Details